ResMed Inc.

11/21/2024 | Press release | Distributed by Public on 11/21/2024 16:21

Proxy Results Form 8 K

Item 5.07.

Submission of Matters to a Vote of Security Holders.

On November 20, 2024, at our annual meeting of stockholders, our stockholders (1) elected the eleven nominees listed below to serve on our board of directors; (2) ratified the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025; and (3) approved, on an advisory basis, the compensation of our named executive officers ("say-on-pay").

For Against Abstain Broker
Non-Votes

Item of business 1: Elect the following eleven directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified:

Carol Burt

105,566,293 4,609,884 81,094 4,969,328

Christopher DelOrefice

109,836,913 337,767 82,591 4,969,328

Jan De Witte

109,745,710 430,055 81,506 4,969,328

Karen Drexler

101,135,602 9,042,745 78,924 4,969,328

Michael Farrell

105,058,243 4,724,177 474,851 4,969,328

Peter Farrell

107,590,325 2,605,639 61,307 4,969,328

Harjit Gill

109,303,018 871,110 83,143 4,969,328

John Hernandez

109,431,549 743,605 82,117 4,969,328

Richard Sulpizio

88,007,747 22,003,356 246,168 4,969,328

Desney Tan

109,241,632 934,672 80,967 4,969,328

Ronald Taylor

95,465,730 14,705,330 86,211 4,969,328
For Against Abstain Broker
Non-Votes

Item of business 2: Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025.

105,082,628 10,096,722 47,249
For Against Abstain Broker
Non-Votes

Item of business 3: Approve, on an advisory basis, the compensation of our named executive officers, as disclosed in our proxy statement ("say-on-pay").

92,885,004 17,284,647 87,620 4,969,328